Skip to main content
. 2018 Mar 4;28(3):e12684. doi: 10.1111/jsr.12684

Figure 2.

Figure 2

Patients treated with sodium oxybate (SXB) showed a decrease in body mass index (BMI) during follow‐up, whereas patients treated with modafinil did not. p‐values are derived from Student's paired t tests comparing normalised BMI values at baseline and at last follow‐up. Mean follow‐up for SXB and modafinil was 2.0 ± 1.7 versus 1.2 ± 1.2 (= .054). *< .05, †< .01, ‡< .001